Medicament inspection and pharmacometrics.
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1998 openaire +2 more sources
Population Physiologically-Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare Disease. [PDF]
CPT Pharmacometrics Syst PharmacolCleary Y +4 more
europepmc +1 more source
Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach. [PDF]
CPT Pharmacometrics Syst PharmacolKumar R +4 more
europepmc +1 more source
The Advance of In Silico Evidence to Transform Pediatric Drug Development for Rare Diseases. [PDF]
CPT Pharmacometrics Syst PharmacolKnöchel J +5 more
europepmc +1 more source
Enhance Multistate Models With Clinically Meaningful Graphs. [PDF]
CPT Pharmacometrics Syst PharmacolGrevel J.
europepmc +1 more source
Response to "Enhance Multistate Models With Clinically Meaningful Graphs". [PDF]
CPT Pharmacometrics Syst PharmacolIbrahim MMA, Kjellsson MC, Karlsson MO.
europepmc +1 more source
Mathematical Modeling of the Role of Cytokines in Sindbis Virus Treatment of Glioblastoma. [PDF]
CPT Pharmacometrics Syst PharmacolMakam S, Dobrovolny HM.
europepmc +1 more source
Development of a Pregnancy-Specific Physiologically Based Pharmacokinetics (PBPK) Model for Aspirin. [PDF]
CPT Pharmacometrics Syst PharmacolCollins-Smith A +5 more
europepmc +1 more source
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model. [PDF]
CPT Pharmacometrics Syst PharmacolBhagunde P +7 more
europepmc +1 more source
Development of a Physiologically Based Model of Bilirubin Metabolism in Health and Disease and Its Comparison With Real-World Data. [PDF]
CPT Pharmacometrics Syst PharmacolSayin AZ, Kuepfer L.
europepmc +1 more source